Podophyllum hexandrum Fraction (REC-2006) Shows Higher Radioprotective Efficacy in the p53-Carrying Hepatoma Cell Line: A Role of Cell Cycle Regulatory Proteins

Abstract

The present study was carried out to evaluate the radioprotective efficacy of Podophyllum hexandrum fraction (REC-2006) in hepatoma cell lines having different p53 statuses. Higher radioresistance was observed in the HepG2 (p53⁺⁺) cell line in comparison to the Hep3B (p53^--) cell line, indicating a plausible role of p53 in radioresistance. REC-2006 exhibited nearly twice the survival in p53-expressing HepG2 cells compared with p53-negative Hep3B cells. REC-2006 treatment alone induced p53 expression as compared with untreated controls. However, REC-2006 reduced p53 expression when treated 2 hours before irradiation as compared with the irradiated HepG2 controls, indicating that REC-2006 modulates the expression of p53 to mitigate its apoptotic effect. Induction of p21 in the REC-2006 + radiation treatment group downregulated the expression of cyclin E and CDK2, leading to a delay in the G1 phase of HepG2 cells, which provided time for DNA repair or related processes. However, no significant difference in CDC2 expression in both cell lines suggested that G2 phase arrest might not be the only responsible factor for REC-2006-mediated radioprotection. Significant induction of PCNA and GADD45 expression in HepG2 cells suggested that REC-2006 increased the percentage survival of HepG2 cells by increasing the span of time as well as efficacy for repair processes. In conclusion, REC-2006 modulated the expression of p53 and thereby promoted cell cycle arrest in the G1 phase, encouraging cell proliferation and DNA repair and thus providing significantly higher protection against acute γ-radiation in the HepG2 cell line.

Keywords

radioprotection p53 HepG2 cells Hep3B cells Podophyllum hexandrum

References

Murray A. Cell cycle checkpoints. Curr Opin Cell Biol. 1994;6:872-876.

Hartwell L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell. 1992;71: 543-546.

Bloom J. , Cross FR Multiple levels of cyclin specificity in cell-cycle control. Nat Rev Mol Cell Biol. 2007;8:149-160.

Sakaquchi K. , Herrera JE , Saito S. , et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 1998;12:2831-2841.

Offer H. , Erez N. , Zurer I. , et al. The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA. Carcinogenesis. 2002;23:1025-1032.

Mallya SM , Sikpi MO Evidence of the involvement of p53 in γ-radiation-induced DNA repair in human lymphoblasts. Int J Radiat Biol. 1998 ;74:231-238.

Liu Y. , Kulesz-Martin M. p53 protein at the hub of cellular DNA damage response pathways through sequence-specific and non-sequence-specific DNA binding. Carcinogenesis. 2001;22: 851-860.

Adimoolam S. , Ford JM p53 and regulation of DNA damage recognition during nucleotide excision repair. DNA Repair. 2003;2:947-954.

Harper JW , Adami GR , Wei N. , Keyomarsi K. , Elledge SJ The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin dependent kinases. Cell. 1993;75:805-816.

10.

Tan M. , Li S. , Swaroop M. , Guan K. , Oberlay LW , Sun Y. Transcriptional activation of the human glutathione peroxidase promoter by p53. J Biol Chem. 1999;274:12061-12066.

11.

Forrester K. , Ambs S. , Lupold SE , et al. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc Natl Acad Sci. 1996;93: 2442-2447.

12.

Grombacher T. , Eichhorn U. , Kaina B. p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents . Oncogene. 1998;17:845-851.

13.

Rafferty JA , Clarke AR , Sellappan D. , Koref MS , Frayling IM , Margison GP Induction of murine O6-alkyalguanine-DNAalkyaltransferase in response to ionizing radiation is p53 gene dose dependent. Oncogene. 1996;12:693-697.

14.

Goel HC , Prasad J. , Sharma A. , Singh B. Antitumour and radioprotective action of Podophyllum hexandrum. Indian J Exp Biol. 1998;36:583-587.

15.

Arora R. , Chawla R. , Puri SC , et al. Radioprotective and antioxidant properties of low-altitude Podophyllum hexandrum (LAPH). J Environ Pathol Toxicol Oncol. 2005;24:299-314.

16.

Gupta D. , Arora R. , Garg AP , Bala M. , Goel HC Modification of radiation damage to mitochondrial system in vivo by Podophyllum hexandrum: mechanistic aspects. Mol Cell Biochem. 2004;266: 65-77.

17.

Kumar R. , Singh PK , Sharma A. , et al. Podophyllum hexandrum (Himalayan mayapple) extract provides radioprotection by modulating the expression of proteins associated with apoptosis . Biotechnol Appl Biochem. 2005;42:81-92.

18.

Kumar R. , Singh PK , Arora R. , et al. Radioprotection by Podophyllum hexandrum in the liver of mice: a mechanistic approach. Environ Toxicol Pharmacol. 2005;20:326-334.

19.

Chawla R. , Arora R. , Kumar R. , et al. Antioxidant activity of fractionated extracts of rhizomes of high-altitude Podophyllum hexandrum: role in radiation protection. Mol Cell Biol. 2005;273:193-208.

20.

Kumar R. , Singh PK , Arora R. , Sharma A. , Sharma RK Modulation of vital proteins expression in intestine of mice by Podophyllum hexandrum: implication in radiation protection. In: Govil JN , eds. Phytomedicine. Houston, TX: Stadium Press; 2006:221-236. Recent Progress in Medicinal Plants; vol 16.

21.

Sagar RK , Chawla R. , Arora R. , et al. Protection of the hemopoietic system by Podophyllum hexandrum against gamma radiation-induced damage. Planta Med. 2006;72:114-120.

22.

Gupta ML , Sanghmitra S. , Verma S. , et al. Whole body protection to lethally irradiated mice by oral administration of semipurified fraction of Podophyllum hexandrum and post irradiation treatment of Picrorhiza kurroa. Tokia J Exp Clin Med. 2008;33:6-12.

23.

Chawla R. , Arora R. , Singh S. , et al. Podophyllum hexandrum offers radioprotection by modulating free radical flux: role of aryl-tetralin lignans. Evid Based Complement Alternat Med. 2006;3:503-511.

24.

Singh PK , Kumar R. , Sharma A. , Arora R. , Jain SK , Sharma RK Pifithrin-α decreases the radioprotective efficacy of Podophyllum hexandrum fraction (REC-2006) in HepG2 cells. Biotechnol Appl Biochem . 2009;54:53-64.

25.

Gowdey G. , Lee RK , Carpenter WM Treatment of HIV-related hairy leukoplakia with podophyllum resin 25% solution . Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:64-67.

26.

Gottlieb TM , Oren M. p53 in growth control and neoplasia. Biochim Biophys Acta. 1996;1287:77-102.

27.

Levine AJ p53, the cellular gatekeeper for growth and division. Cell . 1997;88:323-331.

28.

El-Deiry W. , Tokino T. , Velculescu VE , et al. WAF1, a potential mediator of p53 tumor suppression. Cell.1993;75:817-825.

29.

Schmid G. , Kramer MP , Wesierska-Gadek J. p53-mediated regulation of cell cycle progression: pronounced impact of cellular microenvironment. J Cell Physiol. 2009;219:459-469.

30.

North S. , El-Ghissassi F. , Pluquet O. , et al. The cytoprotective aminothiol WR1065 activates p21waf-1and down regulates cell cycle progression through a p53-dependent pathway. Oncogene. 2000;9:1206-1214.

31.

Park WR , Nakamura Y. p53CSV, a novel p53-inducible gene involved in the p53-dependent cell-survival pathway. Cancer Res. 2005;65:1197-1206.

32.

Johnson RE , Kovvali GK , Guzder SN , et al. Evidence for involvement of yeast proliferating cell nuclear antigen in DNA mismatch repair. J Biol Chem. 1996;271:27987-27990.

33.

Smith ML , Chen IT , Zhan Q. , et al. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science. 1994;266:1376-1380.

34.

Zhang H. , Xiong Y. , Beach D. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell. 1993 ;4:897-906.

35.

Li R. , Waga S. , Hannon G. , Beach D. , Stillman B. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature. 1994;371:534-537.

36.

Waga S. , Hannon G. , Beach D. , Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature. 1994;369:574-578.

37.

Jackson P. , Ridgway P. , Rayner J. , Noble J. , Braithwaite A. Transcriptional regulation of the PCNA promoter by p53. Biochem Biophys Res Commun. 1994;203:133-140.

38.

Morris GF , Bischoff JR , Mathews MB Transcriptional activation of the human proliferating cell nuclear antigen promoter by p53. Proc Natl Acad Sci U S A. 1996;3:895-899.

39.

Shivakumar CV , Brown DR , Deb S. , Deb S. P. Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter. Mol Cell Biol . 1995;15:6785-6793.

40.

Xu J. , Morris GF p53-mediated regulation of proliferating cell nuclear antigen expression in cells exposed to ionizing radiation. Mol Cell Biol. 1999;19:12-20.

41.

Macleod KF , Sherry N. , Hannon G. , et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 1995;9:935-944.

42.

Zhan Q. , Bae I. , Kastan MB , Fornace AJ Jr. The p53-dependent γ-ray response of GADD45. Cancer Res . 1994;54:2755-2760.